





Architecture of high-affinity unnatural-base DNA aptamers 
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Supplementary Table 1. Oligonucleotide sequences used in this study. The 
mini-hairpin DNA sequence is red and underlined. The Ds positions and the 
substitutions from Ds to A are shown in red. The G–C pairs in aptamer 57mhGC that 







Aptamer 26 5′-GGGGTTGGTTGTGTTGGGTGTTGTGT-3′ 
Aptamer 58 5′-TCCACTCGGGTCATTTADsTAATGTAGGTDsTGGGCT
AGGCDsGCTAGTGGACGCGAAGCG-3′ 











Supplementary Fig. 1. Stability analysis of aptamer 49 and control DNAs in 
human serum.  
Each DNA aptamer (5 l, aptamer 49, aptamer 58, aptamer 57mh, and aptamer 
57mhGC; 50 M) or Control DNA (5 l, ssDNA1 and ssDNA2: 50 μM) was mixed 
with human serum (120 l), and the mixture (2 M DNA in 96% serum) was incubated 
at 37C. Aliquots (10 l) were removed at various time points from 0 to 72 hours, and 
mixed with 110 l of denaturing solution (1 TBE containing 10 M urea) immediately. 
Each sample was analyzed by 15% denaturing polyacrylamide gel electrophoresis. 
DNA stained with SYBR Gold was detected with a bio-imaging analyzer (Fuji Film 
LAS-4000) and quantified using the Multi Gauge software to determine the intact 
fraction. The analysis of each sample was repeated twice, and one of them is displayed 
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Supplementary Fig. 2. Thermal stabilities of DNA aptamers and their derivatives. 
UV melting profiles of aptamer 49 (black, solid line), aptamer 49A (black, dotted line), 
aptamer 58 (blue, solid line), aptamer 57 (orange, solid line), and aptamer 57GCmh (red, 
solid line) were recorded, using a SHIMADZU UV-2450 spectrometer equipped with a 
temperature controller (TMSPC-8). The absorbance of each sample (2 μM in 1 mM 
KH2PO4, 3 mM Na2HPO4, and 155 mM NaCl, pH 7.4) was monitored at 260 nm from 
15 to 95°C, at a heating rate of 0.5°C/min. Each melting temperature was calculated by 
the first derivative of the melting curve, using the IGOR Pro software (WaveMetrics, 
Inc.). The melting profiles, normalized by the absorbance at 15°C (left panel), and the 






Supplementary Fig. 3. Stability analysis of DNA aptamer and control DNA in 
human serum.  
The graph showed residual amount (%), aptamer 49 (N=4), aptamer 58 (N=2), aptamer 
57mh (N=2), aptamer 57mhGC (N=2), ssDNA1 50-mer and ssNDA2 50-mer (N=2). 
Each DNA aptamer (5 l, aptamer 49, aptamer 58, aptamer 57mh, and aptamer 
57mhGC; 50 M) or Control DNA (5 l, ssDNA1 and ssDNA2: 50 μM) was mixed 
with human serum (120 l), and the mixture (2 M DNA in 96% serum) was incubated 
at 37C. Aliquots (10 l) were removed at various time points from 0 to 72 hours, and 
mixed with 110 l of denaturing solution (1 TBE containing 10 M urea) immediately. 
Each sample was analysed by 15% denaturing polyacrylamide gel electrophoresis. DNA 
stained with SYBR Gold was detected with a bio-imaging analyzer (Fuji Film 
LAS-4000) and quantified using the Multi Gauge software to determine the intact 


































Supplementary Fig. 4. SPR analysis of each DNA aptamer variant against IFNγ in 
different running buffer and curve fitting with two types of binding model.  
The DNA aptamer immobilization and monitoring of IFN-γ binding to DNA aptamers 
were performed as described in the methods. Running buffer is 1× PBS (1 mM KH2PO4, 
3 mM Na2HPO4 and 155 mM NaCl, pH 7.4, Gibco) supplemented with 0.05%  
(vol/vol) Nonidet P-40, in the presence or absence of the additional 50 mM NaCl (205 
mM or 155 mM NaCl at the final concentration). The data were fitted with a 1:1 binding 
model (Equation 1) or heterogeneous ligand model (Equation 2) as indicated left on 
each sensorgram column, by using the BIAevaluation T200 software, version 1.0 (GE 
Healthcare). In heterogenous ligand model, the KD values of predominant tight binding 
were indicated as KD1, and minor binding (weak binding) as KD2. Fitting curves are 
plotted in black lines.  The dissociation constants and chi square values, obtained from 





Supplementary Fig. 5. Ability of unnatural-base DNA aptamers (50, 100, and 200 
ng/ml) to neutralize human IFNγ (2 ng/ml) induction for STAT1 phosphorylation 











































Supplementary Fig. 6. Ability of aptamer 57GCmh (200 ng/ml) to neutralize 
human IFNγ (2 ng/ml) induction for STAT1 phosphorylation over a 72-hour time 
course (10 min, 24 h, 48 h, and 72 h).  
